Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 49

Sort by

Sort Order Select

Journal Articles

Integration of Geriatric Assessment and Genetic Profile Facilitates Personalized Treatment Selection and Follow-up in Old Patients with Newly Diagnosed Acute Myeloid Leukemia

Pilar Lancho Lavilla, Miguel Lopez-Esteban, Javier Ortiz-Alonso, Gracia Fajardo-Tórtola, Patricia Font Lopez, Marina Gomez Llobell, Jose Antonio Serra Resach, Ana Perez-Corral, Isabel Regalado Artamendi, Mónica Ballesteros Andrés, Carolina Martinez-Laperche, Gloria Figaredo Garcia-Mina, Raquel Fernández González, Carlos Jiménez, Diego Conde Royo, Cristina Pascual Izquierdo, María Teresa Vidán, Ramon García-Sanz, Gabriela Rodriguez Macias

Blood (2024) 144 (Supplement 1): 5050.

https://doi.org/10.1182/blood-2024-203872

Published: 2024

Journal Articles

BONE Marrow Chimerism and Measurable Residual Disease Analysis Interplay: Impact on Prognosis of ACUTE Myeloid Leukemia Undergoing STEM Celltransplatation

Manuel Jorge Fernández Villalobos, Ignacio Alberto Gomez Centurion Luna, Paula Fernández-Caldas, Rebeca Bailen, Pablo Silva, Lucia Castilla Garcia, Ana Perez-Corral, Carolina Martinez-Laperche, Ramon Garcia-Sanz, Mi Kwon

Blood (2024) 144 (Supplement 1): 7447.

https://doi.org/10.1182/blood-2024-210898

Published: 2024

Journal Articles

Donor Chimerism Monitorization for Relapse Prediction in Ex-Vivo CD34-Selected Allogenic Hematopoietic Stem Cell Transplant

Sergi Camarillas, Gilda Coralia Cetina Castro, Alba Puyuelo, Elisa Roldan, Víctor Navarro Garces, Lorenzo Carita, Ana Perez Gonzalez, Maria Sola, Maria Laura Fox, Félix López-Cadenas, Pilar Verlarde, Guillermo Orti, Antonio Garcia, Anna Martín Carrizosa, Marina Serra, Olga Salamero, David Valcarcel

Blood (2024) 144 (Supplement 1): 2129.

https://doi.org/10.1182/blood-2024-208115

Published: 2024

Journal Articles

Outcomes of Patients with Chronic Myeloid Leukemia Who Underwent Allogeneic Stem Cell Transplantation in the Tyrosine Kinase Inhibitors Era

German Jose Wernicke, Alicia I Enrico, Maximiliano Cattaneo, Georgina Emilia Bendek Del Prete, Sofia Pelayes Tortosa, Teofilo De Luca, Gonzalo Bentolila, Martin Castro, Leandro Roberto Castellanos, Martin Saslavsky, María Marta Rivas, Adriana Vitriu, Jorge Alberto Arbelbide, Mariel Ana Perez, Mariano Berro, Ana Lisa Basquiera

Blood (2024) 144 (Supplement 1): 7396.

https://doi.org/10.1182/blood-2024-209075

Published: 2024

Journal Articles

Long-Term Outcomes and Late Complications of Allogeneic Stem Cell Transplant with CD34+ Positive Selection in Adults with Acute Leukaemia and Myelodysplastic Syndrome: A Single-Centre Study

Elisa Roldan, Alba Puyuelo, Sergi Camarillas, Olga Salamero, Ana Perez Gonzalez, Maria Laura Fox, Felix Lopez, Maria Sola, Pere Barba, Guillermo Orti, David Valcarcel

Blood (2024) 144 (Supplement 1): 3545.

https://doi.org/10.1182/blood-2024-205956

Published: 2024

Journal Articles

Assessing Molecular Relapse-Free Survival in Latin American Chronic Myeloid Leukemia Patients Undergoing TKI Dose Reduction

Melina Gisel Luft, Ricardo Khalil Tannuri, María Jose Mela Osorio, Maria Elisa Riva, Beatriz Moiraghi, Ana Ines Varela, Ana Inés Prado, Veronica Ventriglia, Maria Josefina Freitas, Olivia Maria Gelo, Federico Sackmann Massa, Maria Fernanda Tosin, Mariel Ana Perez, Mariana Stevenazzi, Victoria Matosas, Carolina Barreto, Miguel Arturo Pavlovsky, Isolda Isabel Fernandez, Carolina Pavlovsky

Blood (2024) 144 (Supplement 1): 6620.

https://doi.org/10.1182/blood-2024-209195

Published: 2024

Journal Articles

Evaluation of the Prognostic Impact of STAG2 in the Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

Francisco Beas, Sandra Novoa Jáuregui, María Gabarrós-Subirà, María Eugenia Rivero, Clàudia Pellín Jou, Pamela Acha, Alba Puyuelo, Silvia Saumell, Ana María Garrido, Félix López Cadenas, Ana Pérez, Carlos Eduardo Chávez, Adoracion Blanco, Laura Gallur, Gloria Hidalgo-Gómez, Francesc Bosch, Maria Julia Montoro, David Valcarcel, Andres Jerez

Blood (2024) 144 (Supplement 1): 6742.

https://doi.org/10.1182/blood-2024-206758

Published: 2024

Journal Articles

Impact of Transfusion Dependency on Patients Diagnosed with Myelodysplastic Syndrome According to IPSS-M Risk Group

Blood (2024) 144 (Supplement 1): 1838.

https://doi.org/10.1182/blood-2024-205407

Published: 2024

Journal Articles

Clonal Hematopoiesis in Relatives of Adults with Myeloid Neoplasms with Germline Predisposition

Sandra Novoa Jáuregui, Sara Torres-Esquius, Maria Gabarros Subira, Ana María Garrido, Clàudia Pellín Jou, Pamela Acha, Adriana Oñós, Silvia Saumell, Bárbara Tazón-Vega, Ana Perez Gonzalez, Laura Palomo, Adoracion Blanco, David Valcarcel, Francesc Bosch, Andres Jerez, Maria Julia Montoro

Blood (2024) 144 (Supplement 1): 5701.

https://doi.org/10.1182/blood-2024-209611

Published: 2024

Journal Articles

Impact of Antibacterial Prophylaxis on Morbidity-Mortality of Patients with Myeloid Neoplasms Treated with Non-Intensive Venetoclax Combinations

Blood (2023) 142 (Supplement 1): 4270.

https://doi.org/10.1182/blood-2023-186762

Published: 2023

Journal Articles

Results of Treatment Approaches in Myeloid Neoplasms According to TP53 Allelic Status (Multi-hit vs Monoallelic), a Real World Analysis

Maria Sola, Francisco Beas, Laura Palomo, Mar Tormo, Ana Riera, Nicolas Díaz Varela, Teresa Bernal, Sara García, Concepción Fernández, Nieves Garcia-Gisbert, Félix López Cadenas, Barbara Tazon, Adoracion Blanco, Sara Garrido Paniagua, Ana Pérez González, Andres Jerez, Julia Montoro, Olga Salamero, David Valcarcel

Blood (2023) 142 (Supplement 1): 3227.

https://doi.org/10.1182/blood-2023-187101

Published: 2023

Journal Articles

Clinical Impact of the New Bone Marrow Blasts Cutoff Defined By the International Classification Consortium (ICC) in Myeloid Neoplasms with Mutated TP53 gene

Blood (2023) 142 (Supplement 1): 3235.

https://doi.org/10.1182/blood-2023-181698

Published: 2023

Journal Articles

Venetoclax and Azacytidine Treatment for High Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia As a Bridge Therapy to Transplant. a GESMD Study

Blood (2023) 142 (Supplement 1): 1858.

https://doi.org/10.1182/blood-2023-186777

Published: 2023

Journal Articles

Incidence, Risk Factors and Clinical Impact of Sars-Cov-2 Prolonged Viral Shedding in Patients Diagnosed with Hematologic Malignancies

Blood (2023) 142 (Supplement 1): 3927.

https://doi.org/10.1182/blood-2023-191146

Published: 2023

Journal Articles

Bone Marrow Cytokines Concentrations in Myelodysplastic Neoplasms: Its Correlation with the Immune Populations and Clonal Hematopoiesis

Antonieta Molero Yordi, Soraya Peralta Garzón, Laura Gallur, Barbara Tazon, Daniel Medina, Victor Navarro Garces, Maria Julia Montoro, Silvia Saumell, Tamara Jimenez, Félix López Cadenas, Teresa Ezponda, Ana Alfonso Pierola, Felipe Prosper, Maria Diez-Campelo, Olga Salamero, Ana Pérez González, Sara Garrido Paniagua, David Valcarcel

Blood (2023) 142 (Supplement 1): 6457.

https://doi.org/10.1182/blood-2023-185616

Published: 2023

Journal Articles

Role and Prevalence of Risk Factors That Trigger Therapy Related Myeloid Neoplasms (TRMN) in Patients with Previous Treated Breast Cancer

Oriol Calvete, Rashmi Kanagal-Shamanna, Julia Mestre, Guillermo Montalban-Bravo, Courtney D. DiNardo, Koji Sasaki, Jessica Aranda, Pamela Acha, Blanca Xicoy, Ana Pérez González, Laura Palomo, Maria Julia Montoro, Mireia Margeli, Francesc Sole

Blood (2023) 142 (Supplement 1): 4593.

https://doi.org/10.1182/blood-2023-188887

Published: 2023

Journal Articles

Prevalence, Dynamics and Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Newly Diagnosed Cancer Patients

Blood (2023) 142 (Supplement 1): 5593.

https://doi.org/10.1182/blood-2023-189503

Published: 2023

Journal Articles

A Real-World Analysis of Immune Thrombotic Thrombocytopenic Purpura: Comparing Clinical Outcomes of Conventional Treatment Vs Addition of Caplacizumab, a Single-Center Experience

Valeria Estefania Delgado Pinos, Pilar Lancho Lavilla, Marta Moreno Carbonell, Ana Pérez Corral, Cristina Pascual Izquierdo

Blood (2023) 142 (Supplement 1): 2634.

https://doi.org/10.1182/blood-2023-190922

Published: 2023

Journal Articles

IPSS-M Applicability and Clinical Impact in Decision-Making Process in Real-Life Clinical Practice

Sandra Novoa Jáuregui, Laura Palomo, Ana Pérez, Bárbara Tazón, Maria Julia Montoro, Adoracion Blanco, Silvia Saumell, Laura Gallur, Eugenia Rivero, Sara Garrido, Marc Bosch Schips, Sofia Laura Muzio, Margarita Ortega, Antonieta Molero Yordi, Francesc Bosch, David Valcárcel

Blood (2022) 140 (Supplement 1): 6966–6967.

https://doi.org/10.1182/blood-2022-168705

Published: 2022

Journal Articles

Bone Marrow Microenvironment Changes in Myelodysplastic Neoplasms and Its Relationship with Clonal Hematopoiesis and Disease Progression

Antonieta Molero Yordi, Soraya Peralta, Laura Gallur, Bárbara Tazón, Víctor Navarro Garcés, Silvia Saumell, Maria Julia Montoro, Olga Salamero, Ana Pérez González, Sara Garrido, Maria Sola, Tamara Jimenez, Félix López Cadenas, Teresa Ezponda, Ana Alfonso-Pierola, Lídia Altimiras, Maria Diez-Campelo, Felipe Prosper, David Valcárcel

Blood (2022) 140 (Supplement 1): 4024–4025.

https://doi.org/10.1182/blood-2022-163188

Published: 2022

NARROW

Integration of Geriatric Assessment and Genetic Profile Facilitates Personalized Treatment Selection and Follow-up in Old Patients with Newly Diagnosed Acute Myeloid Leukemia

BONE Marrow Chimerism and Measurable Residual Disease Analysis Interplay: Impact on Prognosis of ACUTE Myeloid Leukemia Undergoing STEM Celltransplatation

Donor Chimerism Monitorization for Relapse Prediction in Ex-Vivo CD34-Selected Allogenic Hematopoietic Stem Cell Transplant

Outcomes of Patients with Chronic Myeloid Leukemia Who Underwent Allogeneic Stem Cell Transplantation in the Tyrosine Kinase Inhibitors Era

Long-Term Outcomes and Late Complications of Allogeneic Stem Cell Transplant with CD34+ Positive Selection in Adults with Acute Leukaemia and Myelodysplastic Syndrome: A Single-Centre Study

Assessing Molecular Relapse-Free Survival in Latin American Chronic Myeloid Leukemia Patients Undergoing TKI Dose Reduction

Evaluation of the Prognostic Impact of STAG2 in the Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

Impact of Transfusion Dependency on Patients Diagnosed with Myelodysplastic Syndrome According to IPSS-M Risk Group

Clonal Hematopoiesis in Relatives of Adults with Myeloid Neoplasms with Germline Predisposition

Impact of Antibacterial Prophylaxis on Morbidity-Mortality of Patients with Myeloid Neoplasms Treated with Non-Intensive Venetoclax Combinations

Results of Treatment Approaches in Myeloid Neoplasms According to TP53 Allelic Status (Multi-hit vs Monoallelic), a Real World Analysis

Clinical Impact of the New Bone Marrow Blasts Cutoff Defined By the International Classification Consortium (ICC) in Myeloid Neoplasms with Mutated TP53 gene

Venetoclax and Azacytidine Treatment for High Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia As a Bridge Therapy to Transplant. a GESMD Study

Incidence, Risk Factors and Clinical Impact of Sars-Cov-2 Prolonged Viral Shedding in Patients Diagnosed with Hematologic Malignancies

Bone Marrow Cytokines Concentrations in Myelodysplastic Neoplasms: Its Correlation with the Immune Populations and Clonal Hematopoiesis

Role and Prevalence of Risk Factors That Trigger Therapy Related Myeloid Neoplasms (TRMN) in Patients with Previous Treated Breast Cancer

Prevalence, Dynamics and Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Newly Diagnosed Cancer Patients

A Real-World Analysis of Immune Thrombotic Thrombocytopenic Purpura: Comparing Clinical Outcomes of Conventional Treatment Vs Addition of Caplacizumab, a Single-Center Experience

IPSS-M Applicability and Clinical Impact in Decision-Making Process in Real-Life Clinical Practice

Bone Marrow Microenvironment Changes in Myelodysplastic Neoplasms and Its Relationship with Clonal Hematopoiesis and Disease Progression

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only